石家庄四药

Shijiazhuang No. 4 Pharmaceutical, operating under the listed entity SSY Group Limited, is a leading Chinese pharmaceutical manufacturer specializing in the production of intravenous (IV) infusions and large-volume parenterals. Founded in 1948 and headquartered in Shijiazhuang, the company maintains a dominant position in the Chinese hospital market with a vast portfolio of IV solutions, small-volume injections, and oral preparations. Its therapeutic focus spans anti-infectives, cardiovascular health, respiratory diseases, and electrolyte balance. SSY Group is recognized for its high-capacity, GMP-certified manufacturing facilities utilizing advanced Blow-Fill-Seal (BFS) technology. In addition to its core generics business, the company is actively expanding into the development of innovative small molecule drugs and active pharmaceutical ingredients (APIs).